We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE...
Tilray Medical lance ses premiers produits commerciaux à base de cannabis thérapeutique « cultivés en Allemagne » dans le cadre de son autorisation de culture récemment étendue NEUMÜNSTER...
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License NEUMÜNSTER, Germany, Nov. 14, 2024 (GLOBE NEWSWIRE...
Tilray Medical annonce les résultats positifs d’une étude sur l’extrait de cannabis oral dans le traitement des vomissements induits par la chimiothérapie SYDNEY, Australie, 07 nov. 2024 (GLOBE...
Tilray Medical gibt positive Ergebnisse einer Studie zu oralem Cannabisextrakt bei durch Chemotherapie induziertem Erbrechen bekannt SYDNEY, Australien, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray...
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis SYDNEY, Australia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of...
Tilray Medical bringt die Cannabis-Marke Redecan in Australien auf den Markt EU-GMP-zertifiziertes Redecan Cannabis jetzt in Australien auf ärztliche Verschreibung erhältlichNEW YORK, Sept. 18...
Tilray Medical lance la marque de cannabis Redecan en Australie Le cannabis Redecan, certifié BPF-UE, est désormais disponible sur prescription médicale en AustralieNEW YORK, 18 sept. 2024...
Tilray Medical Launches Redecan Cannabis Brand in Australia EU-GMP Certified Redecan Cannabis Now Available in Australia with Medical PrescriptionNEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE...
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms LISBON...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0224999 | -1.74553155512 | 1.2889999 | 1.3785 | 1.2545 | 156398 | 1.29956622 | DE |
4 | -0.2465 | -16.2921348315 | 1.513 | 1.6695 | 1.2 | 281780 | 1.36065496 | DE |
12 | -0.2135 | -14.4256756757 | 1.48 | 1.6895 | 1.2 | 215431 | 1.46050826 | DE |
26 | -0.4335 | -25.5 | 1.7 | 1.979 | 1.2 | 205574 | 1.57177119 | DE |
52 | -0.4845 | -27.6699029126 | 1.751 | 2.939 | 1.2 | 286857 | 1.80887978 | DE |
156 | -7.1315 | -84.9190283401 | 8.398 | 8.754 | 1.2 | 136567 | 2.19642098 | DE |
260 | -17.1855 | -93.1362453935 | 18.452 | 62.18 | 1.2 | 88324 | 2.85151445 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions